BORTEZOMIB, RITUXIMAB, AND DEXAMETHASONE WITH OR WITHOUT TEMSIROLIMUS IN TREATING PATIENTS WITH UNTREATED OR RELAPSED WALDENSTROM MACROGLOBULINEMIA OR RELAPSED OR REFRACTORY MANTLE CELL OR FOLLICULAR LYMPHOMA: